SCHEMBL4872347

SCHEMBL4872347

Cc1cc(N2CCCCC2)nc(SCCN2CCN(c3ccc(C#N)c4c3OCCO4)CC2)c1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.45
LMNA P02545 5/20 0.45
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
PSMD14 O00487 1/20 0.45
TSHR P16473 6/20 0.43
HSD17B10 Q99714 5/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPT P10636 3/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
NPSR1 Q6W5P4 7/20 0.35
HTT P42858 5/20 0.35
POLB P06746 1/20 0.35
GAA P10253 2/20 0.34
USP2 O75604 1/20 0.34
HPGD P15428 5/20 0.34
MAPK1 P28482 3/20 0.34
PKM P14618 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872373 0.84 ALDH1A1 (0.43) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4871728 0.81 DRD2 (0.42) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4871786 0.80 KMT2A (0.50) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4876083 0.79 DRD2 (0.42) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4870495 0.77 MEN1 (0.42) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4871732 0.76 DRD2 (0.40) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL5119242 0.76 GAA (0.43) ALDH1A1LMNAKMT2AMEN1PSMD14
SCHEMBL4874631 0.75 DRD2 (0.42) DRD2DRD3
SCHEMBL4874829 0.75 DRD2 (0.39) ALDH1A1LMNATSHRHSD17B10TP53
SCHEMBL4874991 0.75 HSD17B10 (0.38) ALDH1A1LMNAKMT2AMEN1PSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US claimed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US claimed
EP-1399438-B1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE LUNDBECK & CO AS H (DK) 2005-12-07 EP claimed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US claimed
EP-1399438-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. Lundbeck A/S (DK) 2004-03-24 EP claimed
WO-2003002556-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 2003-01-09 WO claimed
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US disclosed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US disclosed
EP-1399438-B1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE LUNDBECK & CO AS H (DK) 2005-12-07 EP disclosed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US disclosed
EP-1399438-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. Lundbeck A/S (DK) 2004-03-24 EP disclosed
WO-2003002556-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR1A ALDH1A1 584/4885LMNA 3553/4885KMT2A 2062/4885
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR2C ALDH1A1 1001/4885LMNA 3342/4885KMT2A 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.